FDA approves breakthrough pancreatic cancer drug that nearly doubles survival - El Cronista
FDA approves breakthrough pancreatic cancer drug that nearly doubles survival El Cronista
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →US FDA approves Lilly's Mounjaro to reduce cardiovascular risk Reuters
UToledo’s Northwest Ohio Cancer Research Institute Aims to Speed Up Cancer Breakthroughs UToledo News
WHO appoints 21 leading scientists to help shape future health breakthroughs EnviroNews Nigeria
Cancer Breakthrough Alert: New Russian MRNA Vaccine Shrinks Tumors, Offers Hope Beyond Chemotherapy Rubén Rocha Moya (nr…
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →